VRX
Valeant Pharmaceuticals International Inc
Valeant Pharmaceuticals International Inc Shareholders
VRX Stock Holders 13F
- Number of holders*:
- 7
- AVG reported price*:
- $26.30
- Type:
- Common Stock
7 superinvestors reported owning VRX (Common Stock) according to the gurus' 2016 Q1 reports.
Who were the top gurus owning (VRX) Valeant Pharmaceuticals International Inc in 2016 Q1?
The top 5 super investors (holders) owning VRX (by the percent (%) of portfolio) were Francis Chou - Chou Associates Management (8.35%), Bill Ackman - Pershing Square Capital Management (6.41%), Jeffrey Ubben - ValueAct Holdings (3.94%), Glenn Greenberg - Brave Warrior Advisors (2.61%) and Bill Miller - Miller Value Partners (2.06%) as of their 2016 Q1 reports, among our followed gurus.
Which investors have ever held a position in VRX historically?
Investors including Chou Associates Management, Pershing Square Capital Management, ValueAct Holdings, Brave Warrior Advisors, Miller Value Partners, and others have historically held positions in Valeant Pharmaceuticals International Inc — complete purchase and sale trading data is available for each.
The latest activities of the top VRX shareholders among value investors are tracked each quarter, from new position openings and share additions to reductions and complete exits.
The historical data of VRX holders is tracked quarterly, with each period reflecting disclosed ownership and position sizes.
Completely sold out
Valeant Pharmaceuticals International Inc price chart
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Number of holders: this represents holders from our curated fund list, not all the institutional holders in the world.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.